On 26 June 2014
Dr ReddysLaboratories announced that it has launched Duloxetine Delayed-Release Capsules USP 20mg, 30mg and 60mg, a therapeutic equivalent generic version of CYMBALTA (Duloxetine Delayed-Release Capsules) in the US market on 26 June 2014. Dr Reddy's ANDA was approved by the US Food and Drug Administration (USFDA).Powered by Capital Market - Live News
